-
Eur Heart J: Efficacy of oral anticoagulants in patients with atrial fibrillation at low stroke risk
Time of Update: 2022-04-22
There is currently no consensus on whether patients with atrial fibrillation (AF) at lower risk of stroke (a gender-independent CHA2DS2-VASc score) should receive oral anticoagulation .
-
JAHA: Antithrombotic therapy after intracranial hemorrhage in patients with atrial fibrillation
Time of Update: 2022-04-22
CONCLUSIONS: OACs are recommended for patients with atrial fibrillation and intracranial hemorrhage because they reduce the risk of IS without increasing the risk of subsequent ICH .
OACs are recommended for patients with atrial fibrillation and intracranial hemorrhage because they reduce the risk of IS without increasing the risk of subsequent ICH .
-
JAHA: Oral anticoagulant therapy and dementia risk in patients with atrial fibrillation
Time of Update: 2022-04-21
arrhythmia stroke _Researchers compared the incidence of dementia between oral anticoagulant (OAC) users and non-users in a large cohort of primary care patients with atrial fibrillation .
In patients with atrial fibrillation, the use of OACs may reduce the incidence of dementia compared with treatment with warfarin or no anticoagulant .
-
The gospel of over 15 million atrial fibrillation patients!
Time of Update: 2022-04-15
Recently, there is good news that Sanofi's new anti-arrhythmic drug, Midarone Dronedarone Hydrochloride Tablets, has been launched in China for sinus rhythm patients with a history of paroxysmal or persistent atrial fibrillation (AF).
-
Stroke: Frail patients with atrial fibrillation, better prognosis with anticoagulation
Time of Update: 2022-03-05
All four individual direct OACs were associated with a reduced risk of net adverse clinical events, ischemic stroke, major bleeding, and cardiovascular death compared with warfarin .
All four individual direct OACs were associated with a reduced risk of net adverse clinical events, ischemic stroke, major bleeding, and cardiovascular death .
-
JAHA: Association of neck circumference with risk of atrial fibrillation
Time of Update: 2022-03-04
Researchers selected participants from the Framingham Heart Study who were ≥55 years of age and who had not been diagnosed with atrial fibrillation and had available measurements of neck circumference, BMI, and waist circumference .
-
JAHA: Relationship between ischemic stroke severity and mortality in patients with atrial fibrillation
Time of Update: 2022-03-04
In a contemporary national cohort of ischemic stroke patients, AF patients had more severe stroke and higher mortality compared with non-AF patients .
Ischemic Stroke Severity and Mortality in Patients With and Without Atrial Fibrillation .
-
New strategy for one-stop diagnosis and treatment of atrial fibrillation
Time of Update: 2022-03-02
Xu Yawei said that this treatment strategy can help the majority of patients to formulate more personalized and accurate diagnosis and treatment plans, so as to effectively deal with the risks of atrial fibrillation recurrence, ischemic stroke, and deterioration of cardiac function, and realize the whole process of atrial fibrillation diagnosis and treatment loop closure.
-
JAHA: Risks and benefits of early rhythm control in patients with acute stroke and atrial fibrillation
Time of Update: 2022-02-20
Early rhythm control strategies in patients with acute ischemic stroke reduced persistent AF and recurrent stroke at 12 months without an increase in composite adverse outcomes .
-
JAHA: Effect of body mass index on postoperative atrial fibrillation in patients with hypertrophic cardiomyopathy undergoing septal myectomy
Time of Update: 2022-02-18
Blood vesselThe aim of this study was to determine the effect of body mass index (BMI) on the development of postoperative atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy undergoing septal myectomy .
-
Scissors are still in chaos, the inextricable connection between diabetes and atrial fibrillation
Time of Update: 2022-01-10
In addition, on the population scale, in order to reduce the risk of stroke, it seems reasonable to screen for atrial fibrillation in patients with a CHA2DS2-VASc score ≥2, but this method has not been confirmed in a randomized trial .
-
Atrial fibrillation with diabetes, heart failure or kidney disease
Time of Update: 2022-01-10
In addition to the direct adverse effects of insulin resistance and hyperglycemia on left ventricular dysfunction, the main risk factors that promote the development of heart failure in diabetic patients also include coronary heart disease (CAD), chronic kidney disease (CKD) and hypertension .
-
Stroke prevention in high-risk patients with atrial fibrillation, left atrial appendage occlusion
Time of Update: 2022-01-09
Conclusion The long-term follow-up results of the PRAGUE-17 study showed that for patients with nonvalvular atrial fibrillation at high risk of stroke and bleeding, cardiogenic thromboembolic events, cardiovascular deaths, clinically related bleeding, and surgical/device-related complications in the LAAC treatment group The composite endpoint is not inferior to the NOAC treatment group .
-
JAHA: Homocysteine and uric acid combined to identify high-risk patients with subclinical atrial fibrillation
Time of Update: 2022-01-08
Recently, the heart blood vessels published a research article on the disease areas authoritative magazine JAHA, in patients with cardiac implantable electronic devices, researchers aimed to assess the combination of homocysteine and uric acid (UA) biomarkers to distinguish between SCAF Performance of high-risk patients .
-
Can digestive tract diseases also cause atrial fibrillation?
Time of Update: 2022-01-08
A case report recently published in "Cureus Journal of Medical Science" introduced a case of paroxysmal atrial fibrillation caused by hiatal hernia.